Global Oligonucleotide and Gene Synthesis Market Growth (Status and Outlook) 2024-2030

Global Oligonucleotide and Gene Synthesis Market Growth (Status and Outlook) 2024-2030

DNA Synthesis refers to the process of artificially synthesizing DNA molecules under laboratory conditions. DNA synthesis is usually carried out through chemical synthesis methods, using known nucleotide monomers (A, T, C, G) in a specific order to gradually assemble the target DNA sequence in a test tube. DNA synthesis has a wide range of applications in the field of biotechnology, such as gene cloning, gene editing, synthetic biology and other fields. Scientific researchers and biotechnology companies can use DNA synthesis technology to design and synthesize specific DNA sequences for research on gene function, biomedical research and development, bioinformatics, etc. The development of DNA synthesis technology allows scientists to quickly and accurately synthesize DNA sequences of various lengths and complexities, providing powerful tools and support for life science research and biotechnology applications.

The global Oligonucleotide and Gene Synthesis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Oligonucleotide and Gene Synthesis Industry Forecast” looks at past sales and reviews total world Oligonucleotide and Gene Synthesis sales in 2022, providing a comprehensive analysis by region and market sector of projected Oligonucleotide and Gene Synthesis sales for 2023 through 2029. With Oligonucleotide and Gene Synthesis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide and Gene Synthesis industry.

This Insight Report provides a comprehensive analysis of the global Oligonucleotide and Gene Synthesis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligonucleotide and Gene Synthesis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide and Gene Synthesis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide and Gene Synthesis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide and Gene Synthesis.

United States market for Oligonucleotide and Gene Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Oligonucleotide and Gene Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Oligonucleotide and Gene Synthesis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Oligonucleotide and Gene Synthesis players cover Genescript, Thermo Fisher Scientific, IDT, Eurofins Genomics, DNA 2.0 (ATUM), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide and Gene Synthesis market by product type, application, key players and key regions and countries.

Segmentation by Type:
Oligonucleotide Synthesis
Gene Synthesis

Segmentation by Application:
Commercial
Academic Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Oligonucleotide Synthesis
Gene Synthesis

Segmentation by Application:
Commercial
Academic Research

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec

Please note: The report will take approximately 2 business days to prepare and deliver.